TUBB4A and cancer: As summarized in Fig. 9G, most cancers in Tubb4a WT or heterozygous Tubb4a-cKO TRAMP mice had progressed to poorly differentiated carcinomas (14~15/20) and lymphatic (8/20) and lung (5/20) metastases at 30 weeks of age.